AUTL Earnings Date: Nov 10, 2026 (Estimated) — Autolus Therapeutics plc American Depositary Share
XNAS · Healthcare · Biotechnology
Updated
When is AUTL's next earnings date?
Autolus Therapeutics plc American Depositary Share (AUTL) is expected to report Q3 2026 earnings on Tuesday, November 10, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.21 on revenue of $39.5M.
How did AUTL do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Autolus Therapeutics plc American Depositary Share posted EPS of -$0.15 versus the -$0.21 estimate, a beat of 21.1%. Revenue was $45.7M against a $38.6M estimate. The stock's 1-day post-earnings move was +12.6%.
How much does AUTL stock move after earnings?
AUTL beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 9.5% (up or down) in the day after earnings.
About Autolus Therapeutics plc American Depositary Share
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.21 | -0.15 | +21.05% | $45.7M | ✅ Beat | +12.56% | +10.14% | -1.93% |
| 2026-05-14 | Q1 2026 | -0.27 | -0.27 | +0.00% | $26.2M | ➖ Inline | -7.02% | -5.26% | -8.77% |
| 2026-03-27 | Q4 2025 | -0.38 | -0.34 | +10.53% | $24.3M | ✅ Beat | -6.20% | +9.30% | +10.08% |
| 2025-11-12 | Q3 2025 | -0.23 | -0.30 | -30.43% | $21.2M | ❌ Miss | -9.33% | -14.00% | +6.00% |
| 2025-08-12 | Q2 2025 | -0.24 | -0.18 | +25.00% | $20.9M | ✅ Beat | -12.75% | -23.89% | -44.13% |
| 2025-03-20 | Q4 2024 | -0.24 | -0.09 | +62.50% | $29,000 | ✅ Beat | -13.66% | -15.98% | -26.29% |
| 2024-11-12 | Q3 2024 | -0.21 | -0.31 | -47.62% | $0 | ❌ Miss | -5.13% | -14.81% | -17.38% |
| 2024-08-08 | Q2 2024 | -0.19 | -0.22 | -15.79% | $0 | ❌ Miss | -9.45% | -10.70% | -0.37% |
Showing last 8 quarters.